CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

Por: Barragan, E, Chillon, MC, Castello-Cros, R, Marcotegui, N, Prieto, MI, Hoyos, M, Pippa, R, Llop, M, Etxabe, A, Cervera, J, Rodriguez, G, Buno, I, Rifon, J, Sierra, J, Gonzalez, M, Calasanz, MJ, Sanz, MA, Odero, MD

---

Publicada: 1 may 2015

---

---

Filiaciones:
Barragan, E:
 Univ Hosp La Fe, Clin Lab, Valencia, Spain

 Univ Hosp La Fe, Dept Hematol, Valencia, Spain

Chillon, MC:
 Univ Hosp Salamanca, Salamanca Inst Biomed Res IBSAL, Salamanca, Spain

Castello-Cros, R:
 Univ Navarra, CIMA, Program Hematol Oncol, E-31080 Pamplona, Spain

Marcotegui, N:
 Univ Navarra, CIMA, Program Hematol Oncol, E-31080 Pamplona, Spain

Prieto, MI:
 Univ Hosp Salamanca, Salamanca Inst Biomed Res IBSAL, Salamanca, Spain

Hoyos, M:
 Hosp Santa Creu & Sant Pau, Dept Hematol, E-08025 Barcelona, Spain

Pippa, R:
 Univ Navarra, CIMA, Program Hematol Oncol, E-31080 Pamplona, Spain

Llop, M:
 Univ Hosp La Fe, Clin Lab, Valencia, Spain

 Univ Hosp La Fe, Dept Hematol, Valencia, Spain

Etxabe, A:
 Univ Navarra, CIMA, Program Hematol Oncol, E-31080 Pamplona, Spain

Cervera, J:
 Univ Hosp La Fe, Clin Lab, Valencia, Spain

 Univ Hosp La Fe, Dept Hematol, Valencia, Spain

Rodriguez, G:
 Gregorio Maranon Inst Hlth Res, Dept Hematol, Madrid, Spain

Buno, I:
 Gregorio Maranon Inst Hlth Res, Dept Hematol, Madrid, Spain

Rifon, J:
 Univ Navarra Clin, Dept Hematol, Pamplona, Spain

Sierra, J:
 Hosp Santa Creu & Sant Pau, Dept Hematol, E-08025 Barcelona, Spain

Gonzalez, M:
 Univ Hosp Salamanca, Salamanca Inst Biomed Res IBSAL, Salamanca, Spain

Calasanz, MJ:
 Univ Navarra, Dept Biochem & Genet, E-31080 Pamplona, Spain

Sanz, MA:
 Univ Hosp La Fe, Clin Lab, Valencia, Spain

 Univ Hosp La Fe, Dept Hematol, Valencia, Spain

Odero, MD:
 Univ Navarra, CIMA, Program Hematol Oncol, E-31080 Pamplona, Spain

 Univ Navarra, Dept Biochem & Genet, E-31080 Pamplona, Spain